Candriam SCA’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-13,504
Closed -$3.29M 685
2025
Q1
$3.29M Sell
13,504
-20,243
-60% -$6.09M 0.02% 409
2024
Q4
$11.1M Buy
33,747
+2,220
+7% +$754K 0.06% 248
2024
Q3
$10.5M Buy
31,527
+8,153
+35% +$2.59M 0.06% 267
2024
Q2
$6.38M Sell
23,374
-36,284
-61% -$10.6M 0.04% 308
2024
Q1
$20.6M Sell
59,658
-39,666
-40% -$13M 0.13% 163
2023
Q4
$32.1M Buy
99,324
+26,202
+36% +$8.21M 0.22% 102
2023
Q3
$26.2M Sell
73,122
-18,869
-21% -$7.28M 0.19% 111
2023
Q2
$34.9M Buy
91,991
+7,916
+9% +$3.22M 0.25% 95
2023
Q1
$37.1M Sell
84,075
-2,403
-3% -$1.12M 0.26% 91
2022
Q4
$36.4M Sell
86,478
-9,157
-10% -$3.7M 0.25% 94
2022
Q3
$39.9M Buy
95,635
+25,352
+36% +$12.6M 0.28% 81
2022
Q2
$34.8M Sell
70,283
-407
-0.6% -$212K 0.29% 86
2022
Q1
$39.8M Buy
70,690
+11,652
+20% +$7.02M 0.27% 88
2021
Q4
$44.6M Buy
59,038
+14,195
+32% +$10.6M 0.28% 86
2021
Q3
$33.4M Sell
44,843
-12,415
-22% -$9.3M 0.23% 104
2021
Q2
$36.9M Sell
57,258
-73,514
-56% -$44.7M 0.25% 94
2021
Q1
$73.2M Sell
130,772
-3
-0% -$1.78K 0.61% 32
2020
Q4
$76.2M Buy
130,775
+7,523
+6% +$4.28M 0.6% 32
2020
Q3
$63.5M Buy
123,252
+20,107
+19% +$10.2M 0.6% 32
2020
Q2
$46.6M Buy
103,145
+23,644
+30% +$10.4M 0.49% 40
2020
Q1
$28.8M Buy
79,501
+7
+0% +$2.57K 0.32% 62
2019
Q4
$29.4M Buy
79,494
+11,044
+16% +$3.89M 0.32% 62
2019
Q3
$22.8M Buy
68,450
+23,660
+53% +$7.72M 0.3% 65
2019
Q2
$13.9M Buy
44,790
+1,500
+3% +$449K 0.17% 139
2019
Q1
$13.2M Hold
43,290
0.17% 139
2018
Q4
$10.1M Buy
43,290
+7,040
+19% +$1.89M 0.15% 156
2018
Q3
$11.3M Buy
36,250
+15,850
+78% +$4.92M 0.15% 169
2018
Q2
$5.89M Buy
20,400
+2,900
+17% +$801K 0.09% 266
2018
Q1
$4.38M Buy
17,500
+9,000
+106% +$2.29M 0.07% 307
2017
Q4
$2.03M Buy
+8,500
New +$2.06M 0.04% 450
2017
Q3
Sell
-9,500
Closed -$2.15M 727
2017
Q2
$2.15M Hold
9,500
0.04% 448
2017
Q1
$1.89M Hold
9,500
0.04% 457
2016
Q4
$1.73M Buy
+9,500
New +$1.62M 0.04% 395
2015
Q1
Sell
-38,000
Closed -$4.58M 640
2014
Q4
$4.58M Buy
+38,000
New +$4.37M 0.1% 248

Other funds holding BIO